These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 2652525)

  • 1. Improved cadaver transplant survival using individualized quintuple immunosuppression.
    Cunningham PR; Thomas F; Sash C; Stelzer D; DeMasi R; Clark G; Thomas J
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1615-6. PubMed ID: 2652525
    [No Abstract]   [Full Text] [Related]  

  • 2. Annual trends and triple therapy--1991-2000.
    Nishikawa K; Terasaki PI
    Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cadaver kidney transplantation in Turkey.
    Haberal M; Demirağ A; Cohen B; Turan M; Erdoğan H; Arslan G; Bilgin N
    Transplant Proc; 1995 Oct; 27(5):2768-9. PubMed ID: 7482907
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of immunosuppressive protocols in renal transplantation: a multicenter view.
    Opelz G
    Transplant Proc; 1988 Dec; 20(6 Suppl 8):31-6. PubMed ID: 3059620
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunosuppression in live-related donor renal transplantation.
    Iman A; Rao M; Juneja R; Jacob CK
    Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal allograft function and histology in children on triple immunosuppression based on individual pharmacokinetically determined cyclosporine administration.
    Laine J; Hoppu K; Holmberg C
    Transplant Proc; 1994 Oct; 26(5):2775-6. PubMed ID: 7940874
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunosuppression for recipients of kidneys from non-heart-beating donors: comparison of triple therapy and OKT3 regimens.
    Kehinde EO; Wheatley T; Feehally J; Nicholson ML; Veitch PS; Bell PR
    Transplant Proc; 1996 Jun; 28(3):1338-9. PubMed ID: 8658684
    [No Abstract]   [Full Text] [Related]  

  • 8. Is withdrawal of steroids hazardous to cadaveric renal transplants under treatment with cyclosporine?
    Hillebrand G; Krumme D; Schleibner S; Land W; Gurland HJ
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):126-9. PubMed ID: 3291225
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison between three different antilymphocyte induction protocols in renal transplant recipients with delayed graft function.
    Sumrani N; Hong JH; DiBenedetto A; Clayton R; Miles AM; Markell MS; Distant DA; Fleishhacker J; Sommer BG
    Transplant Proc; 1996 Feb; 28(1):400-1. PubMed ID: 8644289
    [No Abstract]   [Full Text] [Related]  

  • 10. Renal transplantation at Hartford Hospital: results of combined and flexible immunosuppression.
    Schweizer RT; Bow L; Roper L; Hull D; Bartus SA
    Clin Transpl; 1988; ():147-58. PubMed ID: 3154467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute rejection under triple immunosuppressive therapy does not increase the risk of late first cadaveric renal allograft loss.
    Isoniemi H; Kyllönen L; Eklund B; Höckerstedt K; Salmela K; von Willebrand E; Ahonen J
    Transplant Proc; 1995 Feb; 27(1):875-7. PubMed ID: 7879216
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunosuppressive regimens and their effects on renal allograft outcome.
    Katznelson S; Cecka JM
    Clin Transpl; 1996; ():361-71. PubMed ID: 9286582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome after switch from cyclosporine-based triple-drug immunosuppression to double therapy at three months.
    Aichberger C; Eberl T; Riedmann B; Pernthaler H; Ofner D; Königsrainer A; Margreiter R
    Clin Transplant; 1996 Apr; 10(2):209-12. PubMed ID: 8664521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical study and experience in cadaveric kidney transplantation for 15 years.
    Lixin Y; Xiwen B; Junjie M
    Transplant Proc; 1996 Jun; 28(3):1568-70. PubMed ID: 8658788
    [No Abstract]   [Full Text] [Related]  

  • 15. Early steroid withdrawal after renal transplantation.
    Colaneri J
    Nephrol Nurs J; 2006; 33(1):89-90. PubMed ID: 16538935
    [No Abstract]   [Full Text] [Related]  

  • 16. Single-center analysis of 468 first cadaveric kidney allografts with a uniform ATG-CsA sequential therapy.
    Giral M; Taddei C; Nguyen JM; Dantal J; Hourmant M; Cantarovich D; Blancho G; Ancelet D; Soulillou JP
    Clin Transpl; 1996; ():257-64. PubMed ID: 9286575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cadaver kidney transplantation: a retrospective comparison of two immunosuppressive regimens.
    Dandavino R; Barcelo R; Beaudry C; Cardinal J; Carriere S; Friborg J; Houde M; Ouimet D; Bastien E; Girard R; Laplante L
    Transplant Proc; 1982 Dec; 14(4):635-9. PubMed ID: 6762720
    [No Abstract]   [Full Text] [Related]  

  • 18. Steroid withdrawal in kidney transplant recipients: is it a safe option?
    Sanfey H; Haussman G; Isaacs I; Ishitani M; Lobo P; McCullough C; Pruett T
    Clin Transplant; 1997 Oct; 11(5 Pt 2):500-4. PubMed ID: 9361950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kidney graft loss in children: implications for program development.
    Crocker JF; Wade AW; McDonald AT; McLellan DH; Lawen JG; Bitter-Suermann H; Acott PD
    CMAJ; 1998 Aug; 159(3):229-35. PubMed ID: 9724976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved cadaveric kidney graft survival with initiation of antilymphocyte globulin pretransplant in patients with a positive flow cytometry crossmatch.
    Hong JH; Sadeghian M; Sumrani N; Cacciarelli TV; Distant DA; Sommer BG; Norin AJ
    Transplant Proc; 1996 Jun; 28(3):1340-1. PubMed ID: 8658685
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.